Success Metrics

Clinical Success Rate
63.6%

Based on 7 completed trials

Completion Rate
64%(7/11)
Active Trials
1(7%)
Results Posted
71%(5 trials)
Terminated
4(27%)

Phase Distribution

Ph phase_2
5
33%
Ph not_applicable
2
13%
Ph phase_3
2
13%
Ph phase_4
2
13%

Phase Distribution

0

Early Stage

5

Mid Stage

4

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
5(45.5%)
Phase 3Large-scale testing
2(18.2%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
2(18.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

63.6%

7 of 11 finished

Non-Completion Rate

36.4%

4 ended early

Currently Active

1

trials recruiting

Total Trials

15

all time

Status Distribution
Active(2)
Completed(7)
Terminated(4)
Other(2)

Detailed Status

Completed7
Terminated4
unknown2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
1
Success Rate
63.6%
Most Advanced
Phase 4

Trials by Phase

Phase 25 (45.5%)
Phase 32 (18.2%)
Phase 42 (18.2%)
N/A2 (18.2%)

Trials by Status

not_yet_recruiting17%
terminated427%
recruiting17%
completed747%
unknown213%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT06073184Phase 2

Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium

Not Yet Recruiting
NCT00995150Phase 3

A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception

Terminated
NCT05742503

Progesterone Containing Contraceptive Methods on Endogenous Progesterone Level

Completed
NCT05492487Phase 2

A Pilot Study on Fertility Conservative Treatment of Atypical Endometrial Hyperplasia in Singapore

Unknown
NCT03463252Phase 2

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC

Recruiting
NCT03499379

Stress Hormones and IUDs

Completed
NCT02067663

Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study

Completed
NCT02490774Phase 2

To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Further Development

Terminated
NCT02169869Not Applicable

Immediate Postplacental IUD Insertion

Terminated
NCT01299116Phase 4

Long-Acting Reversible Contraception

Completed
NCT02990728Phase 2

Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer

Unknown
NCT01613131Not Applicable

Mirena and Estrogen for Control of Perimenopause Symptoms and Ovulation Suppression

Completed
NCT01750476

Modulation of Mucosal and Systemic Immunity by Hormonal Contraceptives

Terminated
NCT00498784Phase 4

HR-QoL and Sexuality in Mirena Inserted Contraception Users

Completed
NCT01695902Phase 3

Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15